Join
Live feed
·
PRReleasevia Quantisnow
ARS Pharmaceuticals Inc. logo

ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)

ByQuantisnow·Wall Street's wire, on your screen.
SPRY· ARS Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRY (ARS Pharmaceuticals Inc.) and more on Quantisnow.